SMA CARNI-VAL trial part I: double-blind, randomized, placebo-controlled trial of L-carnitine and valproic acid in spinal muscular atrophy (Q21562176)

inferred from title

placebo-controlled trial

1 reference

1 reference

Kristin J. Krosschell

Kristin J Krosschell

Kristin J

Krosschell

1 reference

11 September 2022

Louise R Simard

Louise R

Simard

1 reference

11 September 2022

Kathryn J Swoboda

Kathryn J

Swoboda

1 reference

11 September 2022

Charles B Scott

Charles B

Scott

1 reference

11 September 2022

Thomas O Crawford

Thomas O

Crawford

1 reference

11 September 2022

Sandra P Reyna

Sandra P

Reyna

1 reference

11 September 2022

Gyula Acsadi

Gyula

Acsadi

1 reference

11 September 2022

Bakri Elsheik

Bakri

Elsheik

1 reference

11 September 2022

Mary K Schroth

Mary K

Schroth

1 reference

11 September 2022

Guy D'Anjou

Guy

D'Anjou

1 reference

11 September 2022

Bernard LaSalle

Bernard

LaSalle

1 reference

11 September 2022

Thomas W Prior

Thomas W

Prior

1 reference

11 September 2022

Susan L Sorenson

Susan L

Sorenson

1 reference

11 September 2022

Jo Anne Maczulski

Jo Anne

Maczulski

1 reference

11 September 2022

Mark B Bromberg

Mark B

Bromberg

1 reference

11 September 2022

Gary M Chan

Gary M

Chan

1 reference

11 September 2022

John T Kissel

John T

Kissel

1 reference

Creative Commons Attribution 4.0 International

11 September 2022

language of work or name

English

0 references

publication date

2010

0 references

0 references

0 references

0 references

e12140

0 references

start time

19 August 2010

1 reference

April 2022 Public Data File from Crossref

copyrighted

0 references

cites work

Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924376

The Hammersmith functional motor scale for children with spinal muscular atrophy: a scale to test ability and monitor progress in children with limited ambulation

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924376

Phase II open label study of valproic acid in spinal muscular atrophy

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924376

Multiple therapeutic effects of valproic acid in spinal muscular atrophy model mice

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924376

A modified Hammersmith functional motor scale for use in multi-center research on spinal muscular atrophy

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924376

Population frequencies of inherited neuromuscular diseases—A world survey

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924376

Identification and characterization of a spinal muscular atrophy-determining gene

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924376

A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924376

Literature review: health-related quality of life measurement in pediatric oncology: hearing the voices of the children

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924376

The survival of motor neurons protein determines the capacity for snRNP assembly: biochemical deficiency in spinal muscular atrophy

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924376

Natural history of denervation in SMA: relation to age, SMN2 copy number, and function

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924376

Review of the reliability and validity of myometry with children

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924376

Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924376

A hungarian study on Werdnig-Hoffmann disease

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924376

Incidence, prevalence, and gene frequency studies of chronic childhood spinal muscular atrophy

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924376

Preclinical validation of a multiplex real-time assay to quantify SMN mRNA in patients with SMA

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924376

The role of histone acetylation in SMN gene expression.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924376

Valproic acid increases SMN levels in spinal muscular atrophy patient cells.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924376

Correlation between severity and SMN protein level in spinal muscular atrophy

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924376

Spinal muscular atrophies: recent insights and impact on molecular diagnosis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924376

Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924376

The genetic component in child mortality

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924376

Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2.

30 May 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012140

Homozygous SMN1 deletions in unaffected family members and modification of the phenotype by SMN2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012140

Endogenous alpha-synuclein is induced by valproic acid through histone deacetylase inhibition and participates in neuroprotection against glutamate-induced excitotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012140

Small-sample performance of the robust score test and its modifications in generalized estimating equations

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012140

Epidemiology of neuromuscular disorders in the under-20 population in Bologna province, Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012140

Reliability of hand-held dynamometry in spinal muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012140

Valproic acid treatment in six patients with spinal muscular atrophy

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924376

Benefit of valproic acid in suppressing disease progression of ALS model mice

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924376

Reliability of quantitative muscle testing in healthy children and in children with Duchenne muscular dystrophy using a hand-held dynamometer

29 November 2018

1 reference

12 December 2020

Valproic Acid Promotes Neurite Outgrowth in PC12 Cells independent from Regulation of the Survival of Motoneuron Protein

1 reference

12 December 2020

In vivo activation of SMN in spinal muscular atrophy carriers and patients treated with valproate

1 reference

12 December 2020

Valproate may improve strength and function in patients with type III/IV spinal muscle atrophy

1 reference

12 December 2020

Establishing a standardized therapeutic testing protocol for spinal muscular atrophy

1 reference

12 December 2020

Reference values of maximum isometric muscle force obtained in 270 children aged 4–16 years by hand-held dynamometry

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0012140

Identifiers

DOI

0 references

0 references

0 references